Small non-coding RNAs (sRNAs) are important post-transcriptional regulators in prokaryotes and have been demonstrated to participate in most of the cellular processes. SraG is an sRNA found in several enterobacterial species, but its targets have not been characterized. Here, we compared the protein expression patterns between the wild-type and an sraG-depleted mutant of Yersinia pseudotuberculosis by proteomic analysis. Sixteen proteins were up-or downregulated, and the negative regulatory role of SraG associated with the YPK_1206-1205 operon was confirmed. A region in the coding sequence of YPK_1206 was further demonstrated to be required for this negative regulation.
Introduction
Post-transcriptional regulation by small non-coding RNAs (sRNAs) in bacteria is recognized as an important regulatory mechanism capable of modulating a wide range of cellular processes and physiological responses (Toledo-Arana et al., 2007; Görke & Vogel, 2008) . To date, over 100 sRNAs have been identified in Escherichia coli (Waters & Storz, 2009 ). Most chromosome-encoded sRNAs are found to be trans-encoded sRNAs (Waters & Storz, 2009) , which directly interact with their target mRNAs to influence the translation initiation and/or mRNA stability (Brantl, 2009) , and a short complementary region of about 7-9 bp is commonly required for sRNA-mRNA interaction (Gottesman, 2004; Papenfort et al., 2010) .
Although increasing numbers of sRNAs have been identified in different bacteria, the roles of most remain unknown. SraG is one such sRNA, first reported in E. coli by a computational approach and then verified by Northern blotting (Argaman et al., 2001) . Determination of the 5′ and 3′ ends revealed that the sraG gene is located between pnp (polynucleotide phosphorylase, PNPase) and rpsO (30S ribosomal protein S15) in E. coli and transcribes divergently with pnp and convergently with rpsO (Argaman et al., 2001) . SraG transcripts increase in logarithmic phase, peak in late-logarithmic phase and disappear in late-stationary phase, and are activated by heat and cold shock treatments (Argaman et al., 2001) . Sequence analysis demonstrated that sraG also exists in several other enteric bacteria, e.g. Salmonella, Shigella, Klebsiella and Yersinia (Hershberg et al., 2003; Sridhar et al., 2009) , and the intergenic location of sraG in these bacteria is the same as reported in E. coli (Sridhar et al., 2009) . In Listeria monocytogenes, an sRNA gene named rliD is also located between pnpA and rpsO in a similar way to sraG, although their DNA sequences do not share high similarity (Mandin et al., 2007) .
In this study, we characterized the regulatory targets of SraG in Yersinia pseudotuberculosis. We applied proteomic analysis to compare the global protein expression pattern of wild-type (WT) with an isogenic sraG deletion mutant. Expression levels of 16 proteins were changed more than 1.5-fold in the sraG mutant strain. Of these potential targets, the regulatory role of SraG to YPK_1206-1205 operon was further investigated. The results show that SraG negatively regulates the YPK_1206-1205 operon at the post-transcriptional level and the coding region of YPK_1206 is necessary for this regulation.
Materials and methods

Bacterial strains and growth conditions
Escherichia coli strains were grown in Luria-Bertani (LB) medium at 37°C with either shaking at 180 r.p.m. or statically. Yersinia pseudotuberculosis YpIII and the isogenic mutant strains were grown in YLB medium (Yersinia LB, LB with half the concentration of NaCl) at 28°C unless otherwise stated. Antibiotics (where appropriate) were applied at the following concentrations: 30 lg mL À1 chloramphenicol, 15 lg mL À1 nalidixic acid and 100 lg mL À1 ampicillin.
DsraG and the complemented DsraG strain construction
DsraG was constructed using the suicide plasmid pDM4 (O'Toole et al., 1996) . The +1 site and terminator of SraG was determined by annotation in the NCBI database. To delete the +1 to +184 region of the sraG gene, a 510-bp fragment upstream of the +1 of sraG with SalI and EcoRI and a 505-bp fragment downstream of the +184 of sraG with EcoRI and BglII were amplified by PCR (all primers are listed in Supporting Information, Table S1 ). The fragments were digested with specific restriction enzymes and inserted into the pDM4 plasmid by T4 DNA ligase. The recombinant plasmid was transformed into E. coli S17-1 k-pir. Transconjugation was performed as described previously (Hu et al., 2009) . WT YpIII was used as the parental strain to obtain DsraG in which nucleotides +1 to 184 of the sraG gene were replaced by the EcoRI site. Mutants were verified by both PCR and sequencing.
To construct the SraG complementing plasmid, a plasmid named pRO-SraG was constructed based on the pMD 18-T Vector (TaKaRa). First, the DNA fragment was amplified by PCR to obtain the plasmid backbone containing the lac promoter, ampicillin resistance cassette, pUC replicon and lacZ terminator. The sraG gene was amplified using primers psraGoverlapF and psraG-ER (Table S1 ). The sense primer anneals to the +1 site of sraG and carries a short overlapping fragment with plasmid backbone. The antisense primer binds to the regioñ 100 nt downstream of the SraG terminator and adds an EcoRI site to the PCR product. Overlapping PCR and EcoRI digestion were used to ligate the plasmid backbone and sraG to construct pRO-SraG, which was then electrotransformed into the DsraG strain.
Construction of lacZ fusions and b-galactosidase assay
To construct the translational gene::lacZ fusion, the antisense primer was designed to pair with the exact 3′-end of the coding sequence (CDS), omitting the stop codon with the SpeI site, and the sense primer was designed to pair with the region about 500 nt upstream of the stop codon with the SalI site. The PCR fragment was digested with SpeI and SalI and ligated into the pDM4-lacZ plasmid (Hu et al., 2009 ). The single-copy lacZ fusion was obtained by transconjugation as described previously (Hu et al., 2009) . To construct a series of translational fusions of YPK_1206 fragments with lacZ, the sense primer was designed to pair with sites À549 to À533 corresponding to the translational start site of YPK_1206 with the SalI site, and antisense primers were designed to pair at +3, +9, +36, +48, +63, +75 and +96 site with the SpeI or XbaI site. PCR products were digested with appropriate enzymes and inserted into pDM4-lacZ. Transconjugation was performed in WT and DsraG to obtain crossed single-copy lacZ fusion strains. All strains carrying the single copy of lacZ fusions were cultured to mid-exponential phase (OD 600 nm of~0.6) at 28°C. b-Galactosidase assays were performed as described by Miller (1992) . Results are expressed as the averages of more than three independent assays, and all tests were done in triplicate.
Two-dimensional (2D) gel analysis and protein identification
Overnight cultures of WT and DsraG were grown to exponential phase (OD 600 nm of~0.6) and centrifuged at 5000 g for 5 min at 4°C. Preparation of protein samples, gel electrophoresis and spot quantification were performed as described elsewhere (Hu et al., 2009) . Each sample was prepared and analysed in triplicate. Proteins with densities which increased or decreased ! 1.5-fold in WT compared with that in DsraG in all three experiments were excised, digested with trypsin and identified by MALDI-TOF (matrix-assisted laser desorption ionization time-of-flight) MS.
Western blotting
The coding region of YPK_1205 was amplified using primers p1205eBF and p1205eHR (Table S1 ), digested with BamHI and HindIII and inserted into pET28a (Novagen). Protein was induced and purified as described previously (Hu et al., 2009 ). The purified protein was used to immunize rabbits to obtain serum which was used as a polyclonal anti-YPK_1205 antibody. Overnight cultures were diluted 1/100 in fresh YLB medium and grown to an OD 600 nm of 0.6. Protein samples were prepared and Western blotting was performed as described by Sittka et al. (2007) . Samples were transferred to a polyvinylidene difluoride membrane, hybridized by specific antiserum, and followed by alkaline phosphatase-labelled anti-rabbit IgG (Sigma). NBT/BCIP substrate (BBI) was used to develop the colour.
RNA extraction and semiquantitative RT-PCR
Overnight cultures of WT, DsraG and the complemented DsraG strain were diluted 1 : 100 into fresh YLB medium and cultured to the indicated growth phases. Total RNA was extracted with TRIzol reagent (Invitrogen) according to the manufacturer's protocol. After treatment with RNase-free DNase I (Promega), 4 lg of each RNA sample was used in reverse transcription to obtain the cDNA template. Random 9 mers (TaKaRa) or specific sraG gene primer (pairing with 81-106 of the sraG gene) were used in reverse transcription. The nested PCR was performed to detect SraG RNA transcript. Genomic DNA and DNase Itreated RNA were used as positive and negative controls.
Prediction of the SraG pairing region
Potential interactions of SraG with YPK_1205 and YPK_1206 were predicted with the RNAHYBRID software based on hybridization free energy and interaction site accessibility (Rehmsmeier et al., 2004) . The region of SraG excluding the terminator (1-150) was used as a search seed. The intergenic region between YPK_1207 and YPK_1206 and +1 to +63 according to the translation start site (A of ATG) of YPK_1206 was used as the seed search region.
Results
Expression pattern of SraG in Y. pseudotuberculosis
To characterize the expression pattern of SraG in the Y. pseudotuberculosis YpIII strain, RT-PCR (using an sraG-specific oligo in reverse transcription) was used to examine SraG RNA level at different growth phases. As shown in Fig. 1 , compared with the expression patterns in the sraG deletion mutant and the SraG complementing strains, the transcription levels of SraG are invariable under all tested growth stages. A secondary structure of SraG was predicted ( Fig. S1 ) by RNASTRUCTURE software (Reuter & Mathews, 2010) .
Global analysis of SraG targets in YpIII
To investigate the targets of SraG, we next performed 2D gel analysis to compare the whole-cell protein patterns of WT with DsraG from cultures grown to exponential phase. Expressions of 16 proteins having more than 1.5-fold changes between DsraG and WT (Table 1 and Fig. S2 ). Among these proteins, seven were downregulated and nine were up-regulated.
We next performed semi-quantitative RT-PCR to compare the mRNA levels of these candidate targets. Among these potential targets, only pnp and YPK_1205 (encoding an hypothetical protein) showed significantly different mRNA levels (Fig. S3) .
The YPK_ _1206-1205 operon is negatively regulated by SraG at the post-transcriptional level To confirm the different expression level of YPK_1205 in WT and DsraG (Fig. 2a ), we constructed a single-copy translational fusion of YPK_1205 with lacZ (named 1205zST). b-Galactosidase activities were tested when isogenic strains were grown to mid-log phase. Expression of 1205zST in the DsraG strain was 2.6-fold higher than that in WT (Fig. 2b ). Western blotting also confirmed higher YPK_1205 protein level in DsraG (Fig. 2c ). To further confirm that YPK_1205 mRNA is negatively regulated by SraG, we next performed RT-PCR and observed higher levels of YPK_1205 transcript (based on cDNA level generated by reverse transcription from total RNA) in DsraG than in either WT or the SraG complemented strain (Fig. 2d) . These results are consistent with the result observed by 2D gel analysis and indicate that SraG negatively regulates YPK_1205 mRNA.
The YPK_1205 gene is located downstream of YPK_1206. Inverse RT-PCR was used to examine whether YPK_1206 and YPK_1205 were cotranscribed (there is a 57-bp intergenic region between them, Fig. 3a ). As shown in Fig. 3(b) , a region including both the YPK_1206 and YPK_1205 fragment was amplified from one cDNA template, indicating that the two genes are indeed in one operon. Similar experiments confirmed that Fig. 1 . Expression of SraG under different growth phases. cDNA was reverse transcribed with sraG-specific primers and SraG transcript levels in WT at different growth phases (OD 600 nm at 0.4, 0.8 and 1.2, lanes 3-5) were analysed by RT-PCR. The DsraG strain harbouring the SraG complemented plasmid named SraG-com and DsraG without any plasmid were grown to an OD 600 nm of 0.6 and RNA were purified. Their cDNA were used as positive and negative controls (lanes 6 and 7). Genomic DNA of WT (lane 1) and DsraG (lane 2) was also used as positive and negative controls.
YPK_1206-1205 is not cotranscribed with YPK_1204 or YPK_1207 (data not shown).
The next question was whether expression of YPK_1206 is also regulated by SraG. We therefore constructed a translational fusion of YPK_1206 with lacZ (1206zST), which was transconjugated into both WT and DsraG. Expression of 1206zST was 1.6-fold higher in DsraG than in WT (Fig. 3c, columns 1 and 2) , indicating that YPK_1206 expression is also negatively regulated by SraG. RT-PCR was used to determine the YPK_1206 mRNA level in WT, DsraG and the complementary strains. An increased level of YPK_1206 mRNA was also detected in DsraG compared with that in WT or the SraG complemented strain (Fig. 3d) . These data confirm that the YPK_1206 mRNA is also negatively regulated by SraG.
To investigate whether YPK_1206-1205 mRNA is regulated by SraG at the post-transcriptional level, we constructed a translational fusion with lacZ, which was fused exactly downstream of the translation start site of YPK_1206 (1206z3). Expression of 1206z3 showed no difference in WT and DsraG (Fig. 3c, column 3 and 4 ). This suggests that deletion of the sraG gene has no effect on the upstream untranslated region of the YPK_1206-1205 operon, indicating that SraG regulates YPK_1206-1205 mRNA at the post-transcriptional level.
The CDS of YPK_ _1206 is necessary for SraG-mediated downregulation As mentioned above, the CDS of YPK_1206 is involved in SraG-mediated regulation (Fig. 3c) . To assess whether the CDS of YPK_1206 is necessary for SraG-mediated gene repression, we constructed a series of translational fusions of YPK_1206 with lacZ, which we named 1206z9, 1206z63, 1206z75 and 1206z96 (the number indicates the fusion site according to translational start site in each construct, Fig. 3a ). We did not observe any significant regulation of SraG to the 1206z9 fusion (Fig. 4a, columns  1 and 2) . In contrast, b-galactosidase activities of 1206z63, 1206z75 and 1206z96 were two-to threefold higher in DsraG compared with the WT (Fig. 4a, columns  3-8) . These results suggest that the region of YPK_1206 CDS from nucleotide +9 to nucleotide +63 relative to the translation start site is required for SraG regulation.
To further characterize the binding site of SraG in the YPK_1206-1205 operon, the RNA hybrid software (Rehmsmeier et al., 2004) was used to predict the potential hybrid region. One reasonable interaction region between SraG and the CDS of YPK_1206 from +30 to +38 was found (Fig. 4b) , which was in accordance with our experimental analysis that the region from +9 to +63 was required for SraG-mediated YPK_1206 regulation. To confirm this binding site, we constructed a YPK_1206 translational fusion at +36 (1206z36), which disrupted the predicted paired region (Fig. 3a) . As shown in Fig. 4(a) (columns 9 and 10), no difference was observed between DsraG and the WT. These results indicate that SraG may bind at +30 to +38 of the CDS of YPK_1206, which is necessary for SraG-mediated regulation.
Discussion
In recent years, the regulatory roles of many sRNAs have been characterized, but only a limited number of the corresponding mRNA targets have been identified. Most sRNAs have multiple targets and they induce gene regulation through forming an imperfect RNA duplex (Brantl, 2009; Waters & Storz, 2009) . Therefore, identifying their targets remains a significant challenge. In this study, we used comparative proteomic analysis in combination with subsequent confirmation methods to investigate the regulatory effect of SraG. Our report represents the first attempt to identify the target of SraG in an enteric pathogenic bacterium.
In this study, we focused on the regulatory role of SraG on YPK_1205. Besides YPK_1205, SraG was shown to regulate YPK_1206, which is cotranscribed with YPK_1205. The role of this operon in Yersinia is unknown, although secondary structure prediction using the online software tool PHYRE (Kelley & Sternberg, 2009) suggests that YPK_1206 is an IHF-like DNA bending protein ( Fig. S4 ). Although the amino acid sequences of these two proteins possess low similarity, their secondary structures share high similarity (Swinger & Rice, 2004) . These analyses suggest that YPK_1206 may have roles in DNA bending and SraG may function as a regulatory element in this process. Comparative genomic analysis revealed that the YPK_1206 and YPK_1205 genes are only present in Y. pseudotuberculosis YpIII, Yersinia enterocolitica palearctica and Y. enterocolitica W22703, and YPK_1206 and YPK_1205 in YpIII share 90% similarity with Y. enterocolitica. The interaction region between YPK_1206 and SraG is conserved in both Y. enterocolitica strains, which suggests that SraG may be involved in YPK_1206-1205 operon regulation.
Our results also suggest a role of SraG in YPK_1206-1205 mRNA stability ( Fig. 3 and Fig. S2 ), although further experiments are needed to prove this hypothesis. Our results also revealed that the coding sequence of YPK_1206 is necessary for SraG-mediated regulation, which suggests that SraG may negatively regulate the YPK_1206 mRNA via interaction with this region. This is similar to MicC-induced ompD mRNA regulation, which requires the C terminus of RNase E to be involved (Pfeiffer et al., 2009) . RNase E has an established function in stable RNA, antisense RNA decay and sRNAmediated regulation (Afonyushkin et al., 2005; Pfeiffer et al., 2009) . Decreasing YPK_1206 mRNA level by SraG may also rely upon RNase E, which needs to be further investigated.
It has been shown that PNPase expression is posttranscriptionally regulated by affecting mRNA stability (Briani et al., 2008) . The primary transcript of pnp is very efficiently processed by RNase III, which creates a structure that is susceptible to specific recognition by PNPase, inducing its autocontrol (Briani et al., 2008) . RNA structure prediction by MFOLD (Zuker, 2003) revealed a hairpin structure in the pnp mRNA leader sequence, which could be recognized by RNase III (data not shown). The hairpin region of pnp overlaps with the sraG gene, so deletion of the sraG gene may abrogate the hairpin structure and disrupt the autoregulation of pnp mRNA to increase the expression of PNPase. The effect of SraG on pnp mRNA is under investigation.
Our proteomic analysis revealed that the mutant of sraG regulated expression of 16 proteins. Bioinformatic analysis demonstrated that there is no sequence similarity between those potential targets. However, three proteins are related to maltose metabolism and belong to two adjacent divergently transcribed operons. This suggests that SraG may be also involved in regulation of maltose metabolism. We have used the RNA hybrid algorithm and MFOLD software to predict the SraG binding site on these potential targets. We also did not find a conserved region on SraG that could bind to these potential targets. However, we are trying to validate these potential targets with other methods.
Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31: 3406-3415.
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